tnf-alpha variant fusion molecules
CL202600943A1Pending Publication Date: 2026-08-21TREX BIO INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CL202600943
- Authority / Receiving Office
- CL · CL
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-09-27
- Filing Date
- 2026-03-27
- Publication Date
- 2026-08-21
Abstract
This description refers to TNF-alpha variants and fusion molecules of TNF-alpha variants and their therapeutic uses.
Need to check novelty before this filing date? Find Prior Art